Cargando…
Effects of secondary infections on the multidrug-resistant Tuberculosis: A cohort study
Background: Tuberculosis (TB) causes over a million deaths annually and is still one of the most important public health problems worldwide. According to the World Health Organization estimates, the highest rates of TB in the European Region are in Tajikistan, Kazakhstan, Moldova, Kyrgyzstan, Romani...
Autores principales: | Tabriz, Nurlan, Nurtazina, Zhanara B., Kozhamuratov, Margulan T., Skak, Kuliya, Mutaikhan, Zhumat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683780/ https://www.ncbi.nlm.nih.gov/pubmed/34956951 http://dx.doi.org/10.47176/mjiri.35.105 |
Ejemplares similares
-
Association of polymorphism genes LPL, ADRB2, AGT and AGTR1 with risk of hyperinsulinism and insulin resistance in the Kazakh population
por: Shakhanova, Aizhan, et al.
Publicado: (2020) -
Multidrug-resistant Tuberculosis Lymphadenitis as the Initial Presentation of Secondary Multidrug-resistant Tuberculosis: A Case Report
por: Ogundipe, Temitayo, et al.
Publicado: (2018) -
Factors Associated with the Development of Secondary Multidrug-resistant Tuberculosis
por: Sharma, Parag, et al.
Publicado: (2019) -
Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study
por: Tesfamariam, Sirak, et al.
Publicado: (2021) -
Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)